↓ Skip to main content

Immune checkpoint-targeted antibodies: a room for dose and schedule optimization?

Overview of attention for article published in Journal of Hematology & Oncology, January 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
patent
1 patent
reddit
1 Redditor

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
38 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Immune checkpoint-targeted antibodies: a room for dose and schedule optimization?
Published in
Journal of Hematology & Oncology, January 2022
DOI 10.1186/s13045-021-01182-3
Pubmed ID
Authors

Christophe Maritaz, Sophie Broutin, Nathalie Chaput, Aurélien Marabelle, Angelo Paci

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 38 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 13%
Researcher 5 13%
Other 3 8%
Student > Bachelor 3 8%
Student > Master 2 5%
Other 3 8%
Unknown 17 45%
Readers by discipline Count As %
Medicine and Dentistry 11 29%
Biochemistry, Genetics and Molecular Biology 3 8%
Agricultural and Biological Sciences 2 5%
Immunology and Microbiology 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 1 3%
Unknown 18 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 November 2023.
All research outputs
#7,831,925
of 25,090,809 outputs
Outputs from Journal of Hematology & Oncology
#565
of 1,279 outputs
Outputs of similar age
#180,572
of 550,397 outputs
Outputs of similar age from Journal of Hematology & Oncology
#11
of 18 outputs
Altmetric has tracked 25,090,809 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 1,279 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.4. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 550,397 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.